Autologous hematopoietic stem cell gene therapy for Mucopolysaccharidosis type II
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous hematopoietic stem cell gene therapy for Mucopolysaccharidosis type II, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Gene Therapy With Modified Autologous Hematopoietic Stem Cells for Patients With Mucopolysaccharidosis Type II [Phase 1, Phase 2]